Corporate ActionOct 22, 2026, 05:26 PM
Frazier Life Sciences Acquisition Corp. II Completes IPO and Private Placement
AI Summary
Frazier Life Sciences Acquisition Corp. II announced the consummation of its initial public offering (IPO) and a concurrent private placement. The IPO involved the sale of 7,500,000 Class A ordinary shares at $10.00 per share, raising $75,000,000. Additionally, 300,000 Class A ordinary shares were sold in a private placement to the Sponsor for $3,000,000. A total of $75,000,000 from these proceeds was placed in a U.S.-based trust account. The filing includes an audited balance sheet as of October 15, 2026, detailing assets of $76,837,481 and liabilities of $3,063,953.
Key Highlights
- Frazier Life Sciences Acquisition Corp. II consummated its IPO of 7,500,000 Class A ordinary shares at $10.00 per share.
- Gross proceeds from the IPO amounted to $75,000,000.
- A simultaneous private placement of 300,000 Class A ordinary shares generated an additional $3,000,000 in gross proceeds.
- Total assets reported as of October 15, 2026, were $76,837,481.
- Cash held in the Trust Account was $75,000,000 as of October 15, 2026.
- Total liabilities were $3,063,953 as of October 15, 2026.
- Class A ordinary shares subject to possible redemption were valued at $75,000,000.
Price Impact